Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)

Naoko Hashimoto Takigami, Shimpei Kuniyoshi, Yasuhiro Miki, Kentaro Tamaki, Yoshihiko Kamada, Kano Uehara, Seiko Tsuchiya, Shigeharu Terukina, Erina Iwabuchi, Ayako Kanai, Minoru Miyashita, Takanori Ishida, Nobumitsu Tamaki, Hironobu Sasano

研究成果: Comment/debate査読

抄録

In the original publication of the article, the antibody against GLP-1R which we used in this study was not mouse monoclonaly ab166987 as reported in the manuscript but rabbit polyclonal ab188602, both commercially obtained from Abcam.

本文言語English
ページ(範囲)221
ページ数1
ジャーナルBreast Cancer Research and Treatment
191
1
DOI
出版ステータスPublished - 2022 1

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル